The Antibiotic Resistance Global Market Report 2023, provides comprehensive information on the antibiotic resistance market across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa for the 27 major global industries. The report covers a ten year historic period – 2010-2021, and a ten year forecast period – 2023-2032.
Learn More On The Antibiotic Resistance Market’s Growth:
https://www.thebusinessresearchcompany.com/report/antibiotic-resistance-global-market-report
The global antibiotic resistance market is expected to grow from $10.7 billion in 2022 to $11.43 billion in 2023 at a compound annual growth rate (CAGR) of 6.8%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The antibiotic resistance market is expected to reach $14.4 billion in 2027 at a CAGR of 5.9%.
Get A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample_request?id=12131&type=smp
Product innovations are the key trend gaining popularity in the antibiotic resistance market. Major companies operating in the antibiotic resistance market are focused on developing innovative products to strengthen their position in the market. For instance, in January 2023, Alkem Laboratories Limited, an India-based pharmaceutical company, introduced Zidavi, a novel antibiotic for multi-drug resistant (MDR) infections, to ensure availability, affordability, and accessibility while saving the lives of critically ill patients. Zidavi is a unique combination of ceftazidime and avibactam that can treat infections caused by multi-drug resistant (MDR) gram-negative pathogens. It is available for infusion in sterile powdered concentrate for reconstitution, comprising ceftazidime pentahydrate equivalent to 2 g ceftazidime and avibactam sodium equivalent to 0.5 g avibactam in each single-dose vial. Also, it offers an effective alternative to treat hospital-acquired pneumonia (HAP) and severe intra-abdominal infections (IAIs) caused by meropenem and colistin.
The antibiotic resistance market is segmented:
1) By Drug Class: Beta Lactum Antibiotic, Cephalosporins, Quinolones Antibiotics, Macrolide Antibiotics, Tetracyclines, Oxazolidinones, Other Drug Classes
2) By Pathogen: Staphylococcus aureus, Staphylococcus pneumonia, Neisseria gonorrhoeae, Enterococcus Faecium, Escherichia coli, Klebsiella pneumonia, Shigella, Clostridium difficile, Other pathogens
3) By Disease Type: Urinary tract infection, Intra-abdominal infection, Blood stream infections, Clostridium difficile infections, Other Disease Types
4) By Mechanism of Action: Protein Synthesis Inhibitors, Cell Wall Synthesis Inhibitors, RNA Synthesis Inhibitors, DNA Synthesis Inhibitors, Other Mechanism Of Actions
5) By End Users: Hospitals, Homecare, Specialty clinics, Other End-users
North America was the largest region in the antibiotic resistance market in 2022.
The table of contents in TBRC’s antibiotic resistance market report includes:
1. Executive Summary
2. Antibiotic Resistance Market Characteristics
3. Antibiotic Resistance Market Trends And Strategies
4. Antibiotic Resistance Market – Macro Economic Scenario
5. Impact Of High Inflation On Online Therapy Services Market
……………………………..
32. Global Antibiotic Resistance Market Competitive Benchmarking
33. Global Antibiotic Resistance Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Antibiotic Resistance Market
35. Antibiotic Resistance Market Future Outlook and Potential Analysis
36. Appendix
Learn About Us:
The Business Research Company is a market intelligence firm that pioneers in market, company, and consumer research. TBRC’s specialist consultants are located globally and are experts in a wide range of industries that include healthcare, manufacturing, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries. Through the report businesses can gain a thorough understanding of the market’s size, growth rate, major drivers and leading players.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Overview and Scope Artificial intelligence (AI) in asset management refers to using artificial intelligence (AI)…
Overview and Scope Artificial intelligence in diabetes management refers to using AI technologies and algorithms…
Overview and Scope Menopausal hot flashes, also known as vasomotor symptoms, are common menopausal and…
Overview and Scope The lower respiratory tract refers to the portion of the respiratory system…
Overview and Scope Axial Spondyloarthritis (axSpA) is a chronic inflammatory condition that predominantly impacts the…
Overview and Scope Accounting and budgeting software refers to computer programs or applications designed to…